Alva Review-Courier -

Articles written by Linda A. Johnson

Sorted by date  Results 1 - 25 of 66



Retailers pull Johnson's baby powder after recall

Walmart, CVS and Rite Aid have pulled some or all 22-ounce bottles of Johnson's baby powder from shelves to avoid confusing consumers, after a minuscule amount of asbestos was found in one bottle. Johnson & Johnson recalled all 33,000 bottles from...

 

J&J bolts higher after verdict in Oklahoma opioid case

Johnson & Johnson investors exhaled in relief Tuesday, pushing up the company's shares after an Oklahoma judge imposed a $572 million verdict for the health care giant's role in the nation's opioid crisis. During the seven week trial, state...

 

CARB-X partnership pushes development of new antibiotics

TRENTON, N.J. (AP) — For decades, bacteria have been figuring out ways to outsmart the antibiotics that once easily killed them. Partly due to overuse, the bugs' ability to resist antibiotics is rising, as are the cost and time to treat patients....

 

FDA OKs 1st generic nasal spray of overdose reversal drug

U.S. regulators have approved the first generic nasal spray version of Narcan, a drug that reverses opioid overdoses. The Food and Drug Administration on Friday OK'd naloxone spray from Israel's Teva Pharmaceuticals. Naloxone has been sold as a...

 

FDA approves drug for treating postpartum depression

TRENTON, N.J. (AP) — The U.S. Food and Drug Administration has approved the first drug specifically developed for severe depression after childbirth. The agency on Tuesday approved Sage Therapeutics' Zulresso, an IV drug given over 2 ½ days. Sage...

 

FDA approves 1st immunotherapy drug to treat breast cancer

The U.S. Food and Drug Administration has approved the first immunotherapy drug for breast cancer. Swiss drugmaker Roche's Tecentriq was OK'd Friday for treating advanced triple-negative breast cancer, which accounts for about 15 percent of cases....

 

FDA OKs 1st generic version of popular Advair asthma inhaler

The first generic version of the popular Advair asthma inhaler has been approved by U.S. regulators. The Food and Drug Administration on Wednesday approved Mylan's version in three strengths for ages 4 and up. The inhalers are used twice daily to...

 

FDA OKs powerful opioid pill as alternative to IV painkiller

TRENTON, N.J. (AP) — U.S. regulators on Friday approved a fast-acting, super-potent opioid tablet as an alternative to IV painkillers used in hospitals. The decision by the Food and Drug Administration came over objections from critics who fear...

 

US approves first new type of flu drug in 2 decades

TRENTON, N.J. (AP) — U.S. health regulators have approved the first new type of flu drug in two decades. Wednesday's approval of Xofluza for people age 12 and older comes ahead of the brunt of this winter's flu season. Xofluza is a pill that can...

 

Rising drug prices widen gap between have, have-not patients

TRENTON, N.J. (AP) — For Bridgett Snelten, changing her health insurance meant enduring wild blood sugar swings, bouts of vomiting and weight gain. The Sandy, Utah mother of two young girls has diabetes and has had to change health insurance plans...

 

Drugmakers to disclose prices for medicines advertised on TV

TRENTON, N.J. (AP) — Drugmakers will start disclosing the prices for U.S. prescription drugs that are advertised on TV, but the Trump administration said the move announced Monday doesn't go far enough. The prices won't actually be shown in the TV...

 

FDA expands use of cervical cancer vaccine up to age 45

U.S. regulators Friday expanded the use of Merck's cervical cancer vaccine to adults up to age 45. The vaccine was previously only for preteens and young adults through 26. The Food and Drug Administration approved Gardasil 9 for women and men...

 

FDA approves new pill to reduce pain from endometriosis

TRENTON, N.J. (AP) — A new treatment for pain caused by endometriosis was approved Tuesday by U.S. regulators. The common condition involves abnormal tissue growth from the uterus that can cause severe pain and infertility. Drugmaker Abbvie said...

 

FDA plans to ease OTC approvals for some prescription drugs

U.S. regulators proposed new guidelines Tuesday to make it easier for some common medicines to be sold without a prescription — and more convenient for consumers to get them. The Food and Drug Administration is evaluating ways to make sure...

 

FDA to more aggressively tackle disruptive drug shortages

The U.S. Food and Drug Administration said Thursday it wants to more aggressively fight medication shortages that have led to rationing of some drugs and disrupted patient care. The agency announced plans for a task force to find ways to improve the...

 

FDA OKs 1st drug to treat smallpox, in case of terror attack

U.S. regulators Friday approved the first treatment for smallpox — a deadly disease that was wiped out four decades ago — in case the virus is used in a terror attack. Smallpox, which is highly contagious, was eradicated worldwide by 1980 after...

 

US approves 1st drug developed to prevent chronic migraines

TRENTON, N.J. (AP) — U.S. regulators Thursday approved the first drug designed to prevent chronic migraines. The Food and Drug Administration's action clears the monthly shot Aimovig (AIM'-oh-vig) for sale. It's the first in a new class of...

 

FDA names drugmakers accused of blocking cheaper generics

TRENTON, N.J. (AP) — U.S. drug regulators are publicizing information on brand-name drugmakers that use what government officials call "gaming tactics" to block cheaper copycat versions. The Food and Drug Administration's new webpage names the...

 

FDA approves 1st nonopioid drug to ease withdrawal symptoms

TRENTON, N.J. (AP) — Federal regulators on Wednesday approved the first nonopioid treatment to ease withdrawal from quitting addictive opioids. The U.S. Food and Drug Administration expedited approval of Lucemyra to help combat the U.S. opioid...

 

New data: Americans filling far fewer opioid prescriptions

TRENTON, N.J. (AP) — The number of prescriptions for opioid painkillers filled in the U.S. fell dramatically last year, showing their biggest drop in 25 years and continuing a decline amid increasing legal restrictions and public awareness of the d...

 

Insulin quality questions have diabetes experts scrambling

TRENTON, N.J. (AP) — Preliminary research suggesting that some diabetes patients may be injecting medicine that has partially disintegrated is causing concern even as serious questions are raised about the research itself. The study author, a pharm...

 

Johnson & Johnson loses $10.7B after sweeping US tax changes

Johnson & Johnson posted a rare quarterly loss, a whopping $10.71 billion, due to a $13.6 billion charge related to last month's U.S. tax overhaul. While the loss was expected and the company's adjusted results beat Wall Street expectations, shares...

 

Hospital groups creating company to make cheap generic drugs

TRENTON, N.J. (AP) — Several major not-for-profit hospital groups are trying their own solution to drug shortages and high prices: creating a company to make cheaper generic drugs. The plan, announced Thursday, follows years of shortages of...

 

US OKs 1st drug aimed at women with inherited breast cancer

U.S. regulators have approved the first drug aimed at women with advanced breast cancer caused by an inherited flawed gene. The Food and Drug Administration on Friday approved AstraZeneca PLC's Lynparza for patients with inherited BRCA gene...

 

Viagra goes generic: Pfizer to launch own little white pill

TRENTON, N.J. (AP) — The little blue pill that's helped millions of men in the bedroom is turning white. Drugmaker Pfizer is launching its own cheaper generic version of Viagra rather than lose most sales when the impotence pill gets its first...

 

Page Down

Our Family of Publications Includes:

Powered by ROAR Online Publication Software from Lions Light Corporation
© Copyright 2019